Global Pharmaceutical Contract Manufacturing Market Overview
The Pharmaceutical Contract Manufacturing Market industry required companies to be vertically integrated Contract manufacturing involves the production of goods by the firm, under the brand or label of another firm. Contract manufacturers allow giving several services to various firms based on their own or consumers’ designs, specifications and formulas. The pharmaceutical industry is having the largest share in contract manufacturing.
Global Pharmaceutical Contract Manufacturing Market Dynamics
Increasing the outsourcing volume by big pharmaceutical companies in the major propelling factor for the growth of the global market. Additionally, the expansion in the services that offer by CMOs is another driving factor for the growth of the target market. Moreover, the gradual changes in the working principle of the biotechnology, biopharmaceutical, and pharmaceutical companies in the pharmaceutical CMO market is the boosting factor for the growth of the global market. Furthermore, the increase in investment in research and development is the fueling factor for the growth of the global market. For instance, the US Food and Drug Administration (FDA) regulates the manufacturing of drugs in the United States. It ensures the quality of drug products by carefully monitoring drug manufacturer’s compliance with its (Current Good Manufacturing Practice (CGMP)) regulations. However, the increase in the logistics cost and lead time is the major restraining factor for the growth of the target market. Besides this, stringent rules and regulations requirement is another hampering factor for the growth of the global market.
Global Pharmaceutical Contract Manufacturing Market Segmentation
The global pharmaceutical contract manufacturing market is segmented based on type and region.
Based on the type, the target market is segmented into active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development & manufacturing, and secondary packaging. Active pharmaceutical ingredient (API) manufacturing is the dominating segment for the global pharmaceutical contract manufacturing market due to a rise in the prescription of API than the other drugs.
Regional Insights:
Based on the region the global pharmaceutical contract manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America region is the dominating region for the global pharmaceutical contract manufacturing market because the United States is the world’s largest market for the drugs, and almost half of the R&D funding is spent on the biotechnology and pharmaceutical market. Besides this the Asia Pacific region show the significant growth during the forecast period due to increase in- house investment and companies are also being in partnership based on the research and increasing investment in the manufacturing in the Aisa Pacific region.
Global Pharmaceutical Contract Manufacturing Market, By Type:
- Active Pharmaceutical Ingredient (API) Manufacturing
- Finished Dosage Formulation (FDF) Development & Manufacturing
- Secondary Packaging
Global Pharmaceutical Contract Manufacturing Market, By Region:
- North America
-
-
- North America Pharmaceutical Contract Manufacturing Market, By Type
- North America Pharmaceutical Contract Manufacturing Market, By Country
- The U.S.
- Canada
- Europe
- Europe Pharmaceutical Contract Manufacturing Market, By Type
- Europe Pharmaceutical Contract Manufacturing Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Pharmaceutical Contract Manufacturing Market, By Type
- Asia Pacific Pharmaceutical Contract Manufacturing Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Pharmaceutical Contract Manufacturing Market, By Type
- Latin America Pharmaceutical Contract Manufacturing Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Pharmaceutical Contract Manufacturing Market, By Type
- Middle East & Africa Pharmaceutical Contract Manufacturing Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
-
Global Pharmaceutical Contract Manufacturing Market Key Players
The key players operating the global pharmaceutical contract manufacturing market involves Catalent Inc., Reci pharm AB, Jubilant Life Sciences Ltd., Patheon Inc., Boehringer Ingelheim, Pfizer Centre Source, Aenova Group, Famar S.A., Baxter BioPharma Solutions, and Lonza Group. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in 2017, Catalent announced that it has completed the acquired the Cook Pharmica LLC, and provide the drug substance and drug product manufacturing and related services.
Global Pharmaceutical Contract Manufacturing Market Company Profile
- Catalent Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
- Recipharm AB
- Jubilant Life Sciences Ltd.
- Patheon Inc.
- Boehringer Ingelheim
- Pfizer CentreSource
- Aenova Group
- Famar S.A.
- Baxter BioPharma Solutions
- Lonza Group
“*” marked represents similar segmentation in other categories in the respective section
Global Pharmaceutical Contract Manufacturing Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Pharmaceutical Contract Manufacturing Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Pharmaceutical Contract Manufacturing Market, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Active Pharmaceutical Ingredient (API) Manufacturing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Finished Dosage Formulation (FDF) Development & Manufacturing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Secondary Packaging
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Pharmaceutical Contract Manufacturing Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Catalent Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
- Recipharm AB
- Jubilant Life Sciences Ltd.
- Patheon Inc.
- Boehringer Ingelheim
- Pfizer CentreSource
- Aenova Group
- Famar S.A.
- Baxter BioPharma Solutions
- Lonza Group
- Catalent Inc.
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Pharmaceutical Contract Manufacturing Market report segments the market been segmented on the basis of type and region.
Increasing the outsourcing volume by big pharmaceutical companies in the major propelling factor for the growth of the global market.
North America is estimated to command the largest share of the pharmaceutical contract development and manufacturing market.
The leading players operating in the Pharmaceutical Contract Manufacturing Market Catalent Inc., Reci pharm AB, Jubilant Life Sciences Ltd., Patheon Inc., Boehringer Ingelheim, Pfizer Centre Source, Aenova Group, Famar S.A., Baxter BioPharma Solutions, and Lonza Group.